Nonalcoholic Steatohepatitis
📧 Sign up to get email alerts when something new happens for Nonalcoholic Steatohepatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Evaluation of Miricorilant on Liver Fat in Patients With MASLD [Phase 1]
Phase 1 clinical trial evaluating Miricorilant on liver fat in patients with MASLD, including NASH and related conditions; currently recruit…
-
CLINICAL_TRIALS research · 2026-02-10Clinical Trial Update: Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver. [NA]
A clinical trial update from Université de Sherbrooke indicates recruitment for a study testing niacin to stimulate fat storage in adipose t…
-
CLINICAL_TRIALS research · 2026-02-09Clinical Trial Update: Tocotrienol Against the Progression of End Stage Liver Disease [Phase 2]
Phase 2 clinical trial evaluating tocotrienol to slow progression of end-stage liver disease, including nonalcoholic steatohepatitis and non…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Investigating the Link Between Type 2 Immunity and NAFLD in Human Obesity
A Mayo Clinic-led clinical trial is recruiting to investigate how Type 2 immunity relates to nonalcoholic fatty liver disease (NAFLD) in peo…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Statins for the Treatment of NASH [Phase 2]
A Phase 2 clinical trial evaluating statins for nonalcoholic steatohepatitis (NASH) is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: Nonalcoholic Fatty Liver Disease in HIV Database
This entry describes a clinical trial registry study on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis in people living w…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study
ENDOCare-SCREEN is a screening study for metabolic liver dysfunction and related metabolic conditions, currently not recruiting.
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Hepatic Energy Fluxes in NASH and NAS Patients [NA]
This entry reports an ongoing University of Minnesota clinical trial studying hepatic energy flux in patients with nonalcoholic steatohepati…
-
CLINICAL_TRIALS research · 2025-12-29Clinical Trial Update: A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH ) [Phase 2]
A Phase 2 clinical trial evaluating HP515 for non-alcoholic fatty liver disease, including potential nonalcoholic steatohepatitis, is curren…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream [NA]
A clinical trial evaluating two specialized ice cream formulations (brazzein-based with various sweeteners) for dietary therapy in nonalcoho…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: An Imaging-based Quantitative Biomarker Assay for NAFLD in Children [NA]
This clinical trial update describes an imaging-based quantitative biomarker assay being studied for pediatric nonalcoholic fatty liver dise…
-
CLINICAL_TRIALS research · 2025-12-09Clinical Trial Update: Screening and Follow-up in Patients With HIV Infection Combined With Metabolic Associated Fatty Liver Disease
Recruitment is ongoing for a study examining screening and follow-up in patients with HIV infection and metabolic-associated fatty liver dis…
-
CLINICAL_TRIALS research · 2025-12-04Clinical Trial Update: Using Hydroxychloroquine (HCQ) to Treat Steatohepatitis [Phase 3]
A Phase 3 clinical trial evaluating hydroxychloroquine for nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Non-Invasive Quantification of Liver Health in NASH (N-QUAN) [NA]
The N-QUAN trial, evaluating non-invasive quantification of liver health in nonalcoholic steatohepatitis (NASH), is currently recruiting.
-
CLINICAL_TRIALS research · 2025-12-01Clinical Trial Update: Comparison of ALD, NASH, and Healthy Control Patients
The Cleveland Clinic is recruiting for a clinical trial that compares alcoholic liver disease, nonalcoholic steatohepatitis, and healthy con…
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: Diagnosis and Quantification of Hepatic Steatosis Using Near-infrared Spectroscopy [NA]
A clinical trial sponsored by Assistance Publique Hopitaux De Marseille is evaluating near-infrared spectroscopy to diagnose and quantify he…
-
CLINICAL_TRIALS research · 2025-10-31Clinical Trial Update: Digoxin In NASH (CODIN) [Phase 2]
Phase 2 trial (CODIN) evaluating digoxin for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Study of ADI-PEG 20 Versus Placebo in Subjects With NASH [Phase 2]
Phase 2 clinical trial evaluating ADI-PEG 20 versus placebo in adults with nonalcoholic steatohepatitis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-05Clinical Trial Update: Prevalence of NAFLD and Advanced Fibrosis in Patients With Type 1 Diabetes
Clinical trial assessing the prevalence of nonalcoholic fatty liver disease and advanced liver fibrosis in patients with Type 1 diabetes. Th…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: The Franciscus Obesity NASH Study
Clinical trial registry update for the Franciscus Obesity NASH Study, investigating NAFLD/NASH and obesity. The study status is ACTIVE_NOT_R…
-
CLINICAL_TRIALS research · 2025-08-27Clinical Trial Update: Blood Collection Biorepository for Liver Disease Research
SUNY Buffalo is conducting a blood collection biorepository for liver disease research, currently recruiting participants to provide samples…
-
CLINICAL_TRIALS research · 2025-08-19Clinical Trial Update: a Safety, Tolerability, and Pharmacokinetic Trial of Multiple Subcutaneous Injections of B1344 Injection in Patients With Nonalcoholic Fatty Liver Disease（NAFLD） [Phase 1]
Phase 1 safety, tolerability, and pharmacokinetic study of multiple subcutaneous injections of B1344 in patients with nonalcoholic fatty liv…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Evaluation of Non-Invasive Tests for Metabolic Liver Disease
This clinical trial registry entry describes ongoing evaluation of non-invasive tests for metabolic liver disease, with recruitment currentl…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer Patients [NA]
This ClinicalTrials.gov update indicates a study evaluating whether time-restricted eating plus a healthy diet benefits adults with liver ca…
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: Estrogen Administration for the Treatment of NASH in Postmenopausal Women [Phase 3]
A Phase 3 clinical trial is investigating estrogen administration as a treatment for nonalcoholic steatohepatitis (NASH) in postmenopausal w…